Mechanisms and rational combinations with GP-2250, novel oxathiazine derivative in ovarian...
August 7, 2024 / 0 Minute Read
Let’s engage.
Posts for industry: Publications
Antineoplastic activity of GP-2250 in-vitro and in mouse xenograft models
April 1, 2024 / 17 Second Read
Increasing the cytotoxic effectivity of 5FU, Irinotecan and Oxaliplatin on pancreatic...
March 29, 2024 / 0 Minute Read
GP- 2250, a novel anticancer agent, inhibits the energy metabolism, activates...
December 31, 2023 / 0 Minute Read
Oxathiazinane Derivatives Display Both Anticancer and Antibacterial Activity: A Structure Activity...
December 20, 2023 / 0 Minute Read
An In Vitro Pilot Study Investigating the Antineoplastic Effects of GP-2250...
December 10, 2023 / 0 Minute Read
The effect of GP-2250 on cultured virus-negative Merkel cell carcinoma cells:...
November 11, 2023 / 0 Minute Read
Mechanisms and rational combinations with GP-2250, a novel oxathiazine derivative, in...
November 9, 2023 / 0 Minute Read
In Vitro Experiments on the Effects of GP-2250 on BRAF-Mutated Melanoma...
November 8, 2023 / 0 Minute Read